Bonne Santé Group is Holding Companies in United States that focus on related health business. Founded in 2017. They cover business area such as operator, manufacturing, sale, distribution, operation, nutraceutical and related product, an emphasis, industrial hemp-derive CBD, certain disease, psychological problem, user, health issue, cancer, inflammatory disorder, anxiety, depression, seizure, neurodegenerative disorder, epilepsy.
2017
( 7 years old in 2024 )
Related Health
-
990 Biscayne Boulevard
Suite 1203
Miami, FL 33132
United States
Private
operatormanufacturingsaledistributionoperationnutraceutical and related productan emphasisindustrial hemp-derive CBDcertain diseasepsychological problemuserhealth issuecancerinflammatory disorderanxietydepressionseizureneurodegenerative disorderepilepsy
* We use standard office opening hours in near Bonne Santé Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bonne Santé Group is Holding Companies business from United States that founded in 2017 (7 years old in 2024), Bonne Santé Group business is focusing on Related Health.
Bonne Santé Group headquarter office and corporate office address is located in 990 Biscayne Boulevard Suite 1203 Miami, FL 33132 United States.
Bonne Santé Group was founded in United States.
In 2024, Bonne Santé Group is currently focus on related health sector.
Above is snippet of Google Trends for "related health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bonne Santé Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
